PWR’s 5.7% jump: momentum supports a measured buy

I view the +5.67% move to $616.18 as broadly supported by the data, not a reason to chase aggressively. Q3 revenue rose 57.4% year over year to $12,015M, net income gained 104.7% to $695M, and free cash flow surged 181.6% to $1,186M. Estimates still imply substantial growth: 2026 EPS of $18.166 is forecast up 69.0%, followed by 19.1% growth in 2027. The valuation is the constraint: 55.8x trailing earnings, though the forward multiples fall to 33.9x and 28.5x. Debt/equity of 0.71 is manageable, but the 5.8% net margin leaves execution and cost control important. The rally does not change my view; strong cash generation and growth justify a measured entry, not a full allocation.